Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiri Bronsky

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|March 2, 2017
Endoscopic Recurrence 6 Months After Ileocecal Resection in Children With Crohn Disease Treated With AzathioprineKristyna Zarubova, Ondrej Hradsky, Ivana Copova, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|October 11, 2019
The Impact of Anti-Tumor Necrosis Factor Alpha Therapy on Postoperative Complications in Pediatric Crohn's DiseaseVojtech Dotlacil, Jiri Bronsky, Ondrej Hradsky, et al.
European Journal of Pediatrics|August 26, 2017
Musculoskeletal system in children and adolescents with inflammatory bowel disease: normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fracturesKlara Maratova, Ondrej Hradsky, Jana Matyskova, et al.
Digestive Diseases (Basel, Switzerland)|August 18, 2017
Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels PredictorsJan Ohem, Ondrej Hradsky, Kristyna Zarubova, et al.
Digestive Diseases and Sciences|June 21, 2015
Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel DiseaseOndrej Hradsky, Ivana Copova, Kristyna Zarubova, et al.
Nephrology (Carlton, Vic.)|March 9, 2011
Urinary transforming growth factor-β1 in children with obstructive uropathyJakub Zieg, Kveta Blahova, Tomas Seeman, et al.
Inflammatory Bowel Diseases|March 8, 2017
Supplementation with 2000 IU of Cholecalciferol Is Associated with Improvement of Trabecular Bone Mineral Density and Muscle Power in Pediatric Patients with IBDOndrej Hradsky, Ondrej Soucek, Klara Maratova, et al.
European Journal of Pediatrics|October 4, 2018
Correction to: Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn diseaseIvana Copova, Ondrej Hradsky, Kristyna Zarubova, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|March 30, 2017
Pancreas Divisum in Children and Duodenum-Preserving Resection of the Pancreatic HeadJiri Snajdauf, Ondrej Petru, Jiri Nahlovsky, et al.
European Journal of Pediatrics|August 22, 2018
Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn diseaseIvana Copova, Ondrej Hradsky, Kristyna Zarubova, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Journal of Pediatric Gastroenterology and Nutrition|March 2, 2017
Endoscopic Recurrence 6 Months After Ileocecal Resection in Children With Crohn Disease Treated With AzathioprineKristyna Zarubova, Ondrej Hradsky, Ivana Copova, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|October 11, 2019
The Impact of Anti-Tumor Necrosis Factor Alpha Therapy on Postoperative Complications in Pediatric Crohn's DiseaseVojtech Dotlacil, Jiri Bronsky, Ondrej Hradsky, et al.
European Journal of Pediatrics|August 26, 2017
Musculoskeletal system in children and adolescents with inflammatory bowel disease: normal muscle force, decreased trabecular bone mineral density and low prevalence of vertebral fracturesKlara Maratova, Ondrej Hradsky, Jana Matyskova, et al.
Digestive Diseases (Basel, Switzerland)|August 18, 2017
Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels PredictorsJan Ohem, Ondrej Hradsky, Kristyna Zarubova, et al.
Digestive Diseases and Sciences|June 21, 2015
Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel DiseaseOndrej Hradsky, Ivana Copova, Kristyna Zarubova, et al.
Nephrology (Carlton, Vic.)|March 9, 2011
Urinary transforming growth factor-β1 in children with obstructive uropathyJakub Zieg, Kveta Blahova, Tomas Seeman, et al.
Inflammatory Bowel Diseases|March 8, 2017
Supplementation with 2000 IU of Cholecalciferol Is Associated with Improvement of Trabecular Bone Mineral Density and Muscle Power in Pediatric Patients with IBDOndrej Hradsky, Ondrej Soucek, Klara Maratova, et al.
European Journal of Pediatrics|October 4, 2018
Correction to: Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn diseaseIvana Copova, Ondrej Hradsky, Kristyna Zarubova, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|March 30, 2017
Pancreas Divisum in Children and Duodenum-Preserving Resection of the Pancreatic HeadJiri Snajdauf, Ondrej Petru, Jiri Nahlovsky, et al.
European Journal of Pediatrics|August 22, 2018
Fecal calprotectin is not a clinically useful marker for the prediction of the early nonresponse to exclusive enteral nutrition in pediatric patients with Crohn diseaseIvana Copova, Ondrej Hradsky, Kristyna Zarubova, et al.
Pageof 11